BIOVF Statistics

Total Valuation

BIOVF has a market cap or net worth of 14.15 billion. The enterprise value is 15.28 billion.

Market Cap	14.15B
Enterprise Value	15.28B

Important Dates

The last earnings date was Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	345.66M
Shares Outstanding	n/a
Shares Change (YoY)	+0.59%
Shares Change (QoQ)	+1.16%
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	42.84%
Float	221.73M

Valuation Ratios

The trailing PE ratio is 272.82 and the forward PE ratio is 20.20.

PE Ratio	272.82
Forward PE	20.20
PS Ratio	4.62
PB Ratio	3.46
P/TBV Ratio	n/a
P/FCF Ratio	15.30
P/OCF Ratio	15.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.25, with an EV/FCF ratio of 16.53.

EV / Earnings	294.74
EV / Sales	4.98
EV / EBITDA	12.25
EV / EBIT	17.58
EV / FCF	16.53

Financial Position

The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.30.

Current Ratio	0.90
Quick Ratio	0.59
Debt / Equity	0.30
Debt / EBITDA	1.00
Debt / FCF	1.35
Interest Coverage	9.63

Financial Efficiency

Return on equity (ROE) is 1.22% and return on invested capital (ROIC) is 16.55%.

Return on Equity (ROE)	1.22%
Return on Assets (ROA)	7.00%
Return on Invested Capital (ROIC)	16.55%
Return on Capital Employed (ROCE)	15.58%
Weighted Average Cost of Capital (WACC)	5.26%
Revenue Per Employee	1.62M
Profits Per Employee	27,468
Employee Count	1,888
Asset Turnover	0.40
Inventory Turnover	1.29

Taxes

Income Tax	-47.95M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.78% in the last 52 weeks. The beta is 0.18, so BIOVF's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	+37.78%
50-Day Moving Average	29.87
200-Day Moving Average	23.91
Relative Strength Index (RSI)	75.24
Average Volume (20 Days)	531

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIOVF had revenue of 3.06 billion and earned 51.86 million in profits. Earnings per share was 0.15.

Revenue	3.06B
Gross Profit	2.42B
Operating Income	868.37M
Pretax Income	3.69M
Net Income	51.86M
EBITDA	1.25B
EBIT	868.37M
Earnings Per Share (EPS)	0.15

Full Income Statement

Balance Sheet

The company has 112.94 million in cash and 1.25 billion in debt, giving a net cash position of -1.13 billion.

Cash & Cash Equivalents	112.94M
Total Debt	1.25B
Net Cash	-1.13B
Net Cash Per Share	n/a
Equity (Book Value)	4.09B
Book Value Per Share	11.84
Working Capital	-167.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 929.24 million and capital expenditures -4.34 million, giving a free cash flow of 924.90 million.

Operating Cash Flow	929.24M
Capital Expenditures	-4.34M
Free Cash Flow	924.90M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 78.87%, with operating and profit margins of 28.34% and 1.69%.

Gross Margin	78.87%
Operating Margin	28.34%
Pretax Margin	0.12%
Profit Margin	1.69%
EBITDA Margin	40.68%
EBIT Margin	28.34%
FCF Margin	30.19%

Dividends & Yields

BIOVF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.59%
Shareholder Yield	-0.59%
Earnings Yield	0.37%
FCF Yield	6.54%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIOVF has an Altman Z-Score of 3.36 and a Piotroski F-Score of 7.

Altman Z-Score	3.36
Piotroski F-Score	7